Abstract
Mice are largely resistant to atherosclerosis. However, with dietary intervention or genetic manipulation, mice can be induced to develop atherosclerosis The focus of this chapter is genetically manipulated models (see Chapter 1 for discussion regarding diet-induced atherosclerosis). For a complex genetic disease like atherosclerosis, mouse models provide a suitable means for studying large numbers of animals and a means for manipulating genes thought to be important in lesion development. With the powerful genetic tool that gene-targeted mice provide, we are able to search for the pathogenesis of atherosclerosis, to assess the influence of risk factors, such as elevated plasma glucose or plasma fibrinogen levels, on disease progression. In addition, we can also test the effects of environment, hormones, and drugs on disease progression.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Stary, H. C., Blankenhorn, D. H., Chandler, A. B., Glagov, S., Insull, W., Jr., Richardson, M., Rosenfeld, M. E., Schaffer, S. A., Schwartz, C. J., and Wagner, W. D. (1992) A definition of the intima of human arteries and of its atherosclerosis-prone regions. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Circulation 85, 391–405.
Stary, H. C., Chandler, A. B., Glagov, S., Guyton, J. R., Insull, W., Jr., Rosenfeld, M. E., Schaffer, S. A., Schwartz, C. J., Wagner, W. D., and Wissler, R. W. (1994) A definition of initial, fatty streak, and intermediate lesions of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Circulation 89, 2462–2478.
Stary, H. C., Chandler, A. B., Dinsmore, R. E., Fuster, V., Glagov, S., Insull, W., Jr., Rosenfeld, M. E., Schwartz, C. J., Wagner, W. D., and Wissler, R. W. (1995) A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Circulation 92, 1355–1374.
Nishina P. M., Verstuyft, J., and Paigen, B. (1990) Synthetic low and high fat diets for the study of atherosclerosis in the mouse. J. LipidRes. 31, 859–869.
Ross, R. (1993) The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 362, 801–809.
Plump, A. S., Smith, J. D., Hayek, T., Aalto-Setala, K., Walsh, A., Verstuyft, J. G., Rubin, E. M., and Breslow, J. L. (1992) Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells. Cell 71, 343–353.
Zhang, S. H., Reddick, R. L., Piedrahita, J. A., and Maeda, N. (1992) Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. Science 258, 468–71.
Reddick, R. L., Zhang, S. H., and Maeda, N. (1994) Atherosclerosis in mice lack-ing apo E. Evaluation of lesion development and progression. Arterioscler. Thromb. Vase. Biol. 14, 141–147.
Nakashima, Y., Plump, A. S., Raines, E. W., Breslow, J. L., and Ross, R. (1994) ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree. Arterioscler. Thromb. Vase. Biol. 14, 133–140.
Havekes, L., de Wit, E., Leuven, J. G., Klasen, E., Utermann, G., Weber, W., and Beisiegel, U. (1986) Apolipoprotein E3-Leiden. A new variant of human apolipoprotein E associated with familial type III hyperlipoproteinemia. Hum. Genet. 73, 157–163.
de Knijff, P., van den Maagdenberg, A. M., Stalenhoef, A. F., Gevers Leuven, J. A., Demacker, P. N., Kuyt, L. P., Frants, R. R., Havekes, L. M. (1991) Familial dysbetalipoproteinemia associated with apolipoprotein E3-Leiden in an extent multigeneration pedigree. J. Clin. Invest. 88, 643–655.
van den Maagdenberg, A. M., Hofker, M. H., Krimpenfort, P. J., de Bruijn, I., van Vlijmen, B., van der Boom, H., Havekes, L. M., and Frants, R. R. (1993) Transgenic mice carrying the apolipoprotein E3-Leiden gene exhibit hyperlipoproteinemia. J. Biol. Chem. 268, 10540–10545.
van Vlijmen, B., van den Maagdenberg, A. M., Gijbels, M. J., van der Boom, H., HogenEsch, H., Frants, R. R., Hofker, M. H., and Havekes, L. M. (1994) Dietinduced hyperlipoproteinemia and atherosclerosis in apolipoprotein E3-Leiden transgenic mice. J. Clin. Invest. 93, 1403–1410.
Fazio, S., Sanan, D. A., Lee, Y. L., Ji, Z. S., Mahley, R. W., Rall, S. C. Jr. (1994) Susceptibility to diet-induced atherosclerosis in transgenic mice expressing a dysfunctional human apolipoprotein E(Arg 112,Cys142). Arterioscler. Thromb. Vase. Biol. 14, 1873–1879.
Sullivan, P. M., Mezdour, H., Aratani, Y., Knouff, C., Najib, J., Reddick, R. L., Quarfordt, S. H., and Maeda, N. (1997) Targeted replacement of the mouse apolipoprotein E gene with the common human APOE3 allele enhances diet-induced hypercholesterolemia and atherosclerosis. J. Biol. Chem. 272, 17972–17980.
Sullivan, P. M., Mezdour, H., Quarfordt, S. H., and Maeda, N. (1998) Type III hyperlipoproteinemia and spontaneous atherosclerosis in mice resulting from gene replacement of mouse Apoe with human APOE*2. J. Clin. Invest. 102, 130–135.
Ishibashi, S., Goldstein, J. L., Brown, M. S., Herz, J., and Burns, D. K. (1994) Massive xanthomatosis and atherosclerosis in cholesterol-fed low density lipoprotein receptor-negative mice. J. Clin. Invest. 93, 1885–1893.
Callow, M. J., Verstuyft, J., Tangirala, R., Palinski, W., and Rubin, E. M. (1995) Atherogenesis in transgenic mice with human apolipoprotein B and lipoprotein (a). J. Clin. Invest. 96, 1639–1646.
Purcell-Huynh, D. A., Farese, R. V. Jr., Johnson, D. F., Flynn, L. M., Pierotti, V., Newland, D. L., Linton, M. F., Sanan, D. A., and Young, S. G. (1995) Transgenic mice expressing high levels of human apolipoprotein B develop severe atherosclerotic lesions in response to a high-fat diet. J. Clin. Invest] 95, 2246–2257.
Lawn, R. M., Wade, D. P., Hammer, R. E., Chiesa, G., Verstuyft, J. G., and Rubin, E. M. (1992) Atherogenesis in transgenic mice expressing human apolipoprotein. Nature 360, 670–672.
Mancini, F. P., Newland, D. L., Mooser, V., Murata, J., Marcovina, S., Young, S. G., Hammer, R. E., Sanan, D. A., and Hobbs, H. H. (1995) Relative contributions of apolipoprotein(a) and apolipoprotein-B to the development of fatty lesions in the proximal aorta of mice. Arterioscler. Thromb. Vasc. Biol. 15, 1911–1916.
Boring, L., Gosling, J., Cleary, M., and Charo, I. F. (1998) Decreased lesion formation in CCR2-/-mice reveals a role for chemokines in the initiation of atherosclerosis. Nature 394, 894–897.
Plump, A. S., Scott, C. J., and Breslow, J. L. (1994) Human apolipoprotein A-1 gene expression increases high density lipoprotein and suppresses atherosclerosis in the apolipoprotein E-deficient mouse. Proc. Natl. Acad. Sci. USA 91, 9607–9611.
Pászty, C., Maeda, N., Verstuyft, J., and Rubin, E. M. (1994) Apolipoprotein AI transgene corrects apolipoprotein E deficiency-induced atherosclerosis in mice. J. Clin. Invest. 94, 899–903.
Linton, M. F., Atkinson, J. B., and Fazio, S. (1995) Prevention of atherosclerosis in apolipoprotein E-deficient mice by bone marrow transplantation. Science 267, 1034–1037.
Zhang, S. H., Reddick, R. L., Avdievich, E., Surles, L. K., Jones, R. G., Reynolds, J. B., Quarfordt, S. H., and Maeda, N. (1997) Paradoxical enhancement of atherosclerosis by probucol treatment in apolipoprotein E-deficient mice. J. Clin. Invest. 99, 2858–2566.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2001 Humana Press Inc., Totowa, NJ
About this protocol
Cite this protocol
Xiao, Q. (2001). Genetically Manipulated Models of Atherosclerosis in Mice. In: Drew, A.F. (eds) Atherosclerosis. Methods in Molecular Medicine™, vol 52. Humana Press. https://doi.org/10.1385/1-59259-073-X:15
Download citation
DOI: https://doi.org/10.1385/1-59259-073-X:15
Publisher Name: Humana Press
Print ISBN: 978-0-89603-751-9
Online ISBN: 978-1-59259-073-5
eBook Packages: Springer Protocols